Country websites

Attention

The medical device and therapy related information on this website is aimed exclusively at healthcare professionals.

The product related information on the websites covers – unless explicitly stated otherwise – only CE marked products which are marketable in the European Union. Please be aware that not all products and services described on the following website are cleared or available for sale in all countries. Please check the relevant country web site for details.

By clicking the button “Accepted and Confirmed” you assure that you have taken note of this information.

Medical information

high-quality and reliable clinical and scientific information

Fresenius Medical Care is dedicated to delivering the most up-to-date, high-quality and reliable clinical and scientific information on our products to healthcare professionals and patients .

2024

pdf

Important information on the use of the stay•safe

PDF, 190 KB

2023

pdf

Statement Regarding Voluntary Recall of Sanxin Single Use Sterile Syringes

PDF, 97 KB
pdf

Statement regarding voluntary recall of 2008T hemodialysis machines

PDF, 159 KB

2020-2022

pdf

2008 Series Hemodialysis Machine Release

PDF, 154 KB
pdf

2008 Series Hemodialysis Machine Spare Parts Release

PDF, 100 KB
pdf

Fresenius Medical Care Field Notification - Silicone tubing in hemodialysis machines

PDF, 145 KB
pdf

Further statement on the withdrawal of APEX time on POL 6.2

PDF, 583 KB
pdf

ECMO (ExtraCorporeal Membrane Oxygenation) in Covid-19 Disease 

PDF, 196 KB
pdf

Statement on investigations of CorDiax-associated adverse events 

PDF, 520 KB
pdf

The Role and Benefit of Extracorporeal Blood Purification in Critically Ill COVID-19 Patients

PDF, 199 KB

1 ECMO enables gas exchange and circulation, respectively, when standard treatment fails — thus providing clinicians time to treat patients; despite a currently unclear overall benefit ECMO numbers in COVID-19 are increasing rapidly in Europe and USA.

2 Fresenius Medical Care initiated a project in 2015 with the intent to investigate the root cause of certain hypersensitivity-like adverse events associated with dialyzers of the CorDiax product line. The project was completed in 2019 and reported to the Management Board of Fresenius Medical Care. This communication serves as a high-level summary of the findings and conclusions of the investigation.